XPO1exportin 1
Autism Reports / Total Reports
7 / 12Rare Variants / Common Variants
32 / 1Aliases
XPO1, CRM-1, CRM1, emb, exp1Associated Syndromes
-Chromosome Band
2p15Associated Disorders
-Relevance to Autism
In XPO1, rs6735330 was associated with autism in all four cohorts (P<0.05), being significant in ASD-CARC cohorts (P-value following false discovery rate correction for multiple testing (P(FDR))=1.29 x 10(-5)), the AGRE cohort (P(FDR)=0.0011) and the combined families (P(FDR)=2.34 x 10(-9)). These results indicate that deletion 2p15-p16.1 is not commonly associated with idiopathic ASD, but represents a novel contiguous gene syndrome associated with a constellation of phenotypic features (autism, intellectual disability, craniofacial/CNS dysmorphology), and that XPO1 may contribute to ASD in 2p15-p16.1 deletion cases and non-deletion cases of ASD mapping to this chromosome region. van Oirsouw et al., 2025 collected the clinical data of 22 individuals with de novo XPO1 variants [11 individuals with putative loss-of-function variants and 11 with coding variants (10 missense variants and one in-frame deletion variant)] through online matchmaking and identified an overlapping phenotype consistent with a monogenic neurodevelopmental disorder characterized by developmental delay and/or intellectual disability, microcephaly, structural brain abnormalities, behavioral problems, dysmorphic features, and different organ anomalies; 5/11 individuals with a missense or in-frame deletion variant in XPO1 were reported to have autism spectrum disorder, compared to only 1/11 individuals with a putative loss-of-function variant (45% vs. 9%). Additional functional studies of XPO1 in Drosophila in van Oirsouw et al., 2025 demonstrated that GABAergic neuron-specific knockdown flies demonstrated impaired habituation. A total of six de novo missense variants in XPO1 (five of which had a MPC >2) were previously identified in five ASD probands from the Autism Sequencing Consortium, the SPARK cohort, and the Simons Simplex Collection (Satterstrom et al., 2020; Zhou et al., 2022; Fu et al., 2022).
Molecular Function
The protein encoded by this gene mediates leucine-rich nuclear export signal (NES)-dependent protein transport. Exportin 1 specifically inhibits the nuclear export of Rev and U snRNAs. It is involved in the control of several cellular processes by controlling the localization of cyclin B, MPAK, and MAPKAP kinase 2. This protein also regulates NFAT and AP-1.
SFARI Genomic Platforms
Reports related to XPO1 (12 Reports)
| # | Type | Title | Author, Year | Autism Report | Associated Disorders |
|---|---|---|---|---|---|
| 1 | Primary | 2p15-p16.1 microdeletion syndrome: molecular characterization and association of the OTX1 and XPO1 genes with autism spectrum disorders | Liu X , et al. (2011) | Yes | - |
| 2 | Support | Haploinsufficiency of XPO1 and USP34 by a de novo 230 kb deletion in 2p15, in a patient with mild intellectual disability and cranio-facial dysmorphisms | Fannemel M , et al. (2014) | No | - |
| 3 | Support | Identifying candidate genes for 2p15p16.1 microdeletion syndrome using clinical, genomic, and functional analysis | Bagheri H , et al. (2016) | No | - |
| 4 | Support | Molecular and clinical delineation of 2p15p16.1 microdeletion syndrome | Lvy J , et al. (2017) | No | Motor delay, behavioral problems |
| 5 | Support | Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder | Lim ET , et al. (2017) | Yes | - |
| 6 | Support | Exome sequencing of 457 autism families recruited online provides evidence for autism risk genes | Feliciano P et al. (2019) | Yes | - |
| 7 | Support | Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism | Satterstrom FK et al. (2020) | Yes | - |
| 8 | Support | Inhibition of Autism-Related Crm1 Disrupts Mitosis and Induces Apoptosis of the Cortical Neural Progenitors | Li X , et al. (2020) | No | - |
| 9 | Support | - | Zhou X et al. (2022) | Yes | - |
| 10 | Support | - | Fu JM et al. (2022) | Yes | - |
| 11 | Support | - | Soo-Whee Kim et al. (2024) | Yes | - |
| 12 | Recent Recommendation | - | Amber S E van Oirsouw et al. () | No | ASD, epilepsy/seizures |
Rare Variants (32)
| Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Parental Transmission | Family Type | PubMed ID | Author, Year |
|---|---|---|---|---|---|---|---|---|
| - | - | copy_number_loss | De novo | - | - | 28573701 | Lvy J , et al. (2017) | |
| - | - | copy_number_loss | Unknown | - | - | 28573701 | Lvy J , et al. (2017) | |
| - | - | copy_number_loss | De novo | - | - | 24911659 | Fannemel M , et al. (2014) | |
| - | - | copy_number_gain | De novo | - | - | 31452935 | Feliciano P et al. (2019) | |
| c.2150T>G | p.Met717Arg | missense_variant | De novo | - | - | 35982160 | Fu JM et al. (2022) | |
| c.656C>T | p.Ala219Val | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
| c.1467G>C | p.Trp489Cys | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
| c.1927G>A | p.Ala643Thr | missense_variant | De novo | - | - | 35982159 | Zhou X et al. (2022) | |
| c.315C>G | p.Tyr105Ter | stop_gained | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.553C>T | p.Gln185Ter | stop_gained | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.913C>T | p.Arg305Ter | stop_gained | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.775A>G | p.Met259Val | missense_variant | De novo | - | - | 39334436 | Soo-Whee Kim et al. (2024) | |
| c.2293C>T | p.Arg765Ter | stop_gained | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.1675T>A | p.Trp559Arg | missense_variant | De novo | - | Simplex | 35982160 | Fu JM et al. (2022) | |
| c.888+1G>A | p.? | splice_site_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.1887+1G>T | p.? | splice_site_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.579T>G | p.His193Gln | missense_variant | De novo | - | Multiplex | 28714951 | Lim ET , et al. (2017) | |
| c.1343C>A | p.Thr448Lys | missense_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.1361A>G | p.Tyr454Cys | missense_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.1537G>A | p.Glu513Lys | missense_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.1575A>C | p.Leu525Phe | missense_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.1704G>T | p.Lys568Asn | missense_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.1949A>C | p.Gln650Pro | missense_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.2146G>T | p.Asp716Tyr | missense_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.2150T>G | p.Met717Arg | missense_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.2525C>G | p.Pro842Arg | missense_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.2738G>T | p.Ser913Ile | missense_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.2022+886_2314-728del | - | copy_number_loss | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.639+3_639+6del | p.? | splice_site_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.1643_1645del | p.Val548del | inframe_deletion | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.1282del | p.Glu428ArgfsTer6 | frameshift_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () | |
| c.3014_3018del | p.Asn1005ArgfsTer22 | frameshift_variant | De novo | - | - | 40819229 | Amber S E van Oirsouw et al. () |
Common Variants (1)
| Status | Allele Change | Residue Change | Variant Type | Inheritance Pattern | Paternal Transmission | Family Type | PubMed ID | Author, Year |
|---|---|---|---|---|---|---|---|---|
| c.302-2033C>T;c.104-2033C>T;c.-92-2033C>T;c.-93-4449C>T;c.-2022-2033C>T | - | intron_variant | - | - | - | 21750575 | Liu X , et al. (2011) |
SFARI Gene score
Strong Candidate

A SNP in the XPO1 gene (rs6735330) was found to associate with autism in four cohorts, being significant in ASD-CARC cohorts (P-value following false discovery rate correction for multiple testing of 1.29E-05), the AGRE cohort [P(FDR)=0.0011] and the combined families [P(FDR)=2.34E-09] (Liu et al., 2011). XPO1 has been proposed to be a candidate gene for 2p16.1-p15 microdeletion syndrome, a neurodevelopmental disorder in which many patients present with autism or autistic features. Functional analysis of candidate genes for 2p16.1-p15 microdeletion syndrome in zebrafish found that knockdown of xpo1a, one of the two copies of XPO1 in zebrafish, resulted in significant microcephaly and abnormal body shape (Bagheri et al., 2016).
Score Delta: Score remained at 2
criteria met
See SFARI Gene'scoring criteriaWe considered a rigorous statistical comparison between cases and controls, yielding genome-wide statistical significance, with independent replication, to be the strongest possible evidence for a gene. These criteria were relaxed slightly for category 2.
4/1/2022

Decreased from 3 to 2
Description
A SNP in the XPO1 gene (rs6735330) was found to associate with autism in four cohorts, being significant in ASD-CARC cohorts (P-value following false discovery rate correction for multiple testing of 1.29E-05), the AGRE cohort [P(FDR)=0.0011] and the combined families [P(FDR)=2.34E-09] (Liu et al., 2011). XPO1 has been proposed to be a candidate gene for 2p16.1-p15 microdeletion syndrome, a neurodevelopmental disorder in which many patients present with autism or autistic features. Functional analysis of candidate genes for 2p16.1-p15 microdeletion syndrome in zebrafish found that knockdown of xpo1a, one of the two copies of XPO1 in zebrafish, resulted in significant microcephaly and abnormal body shape (Bagheri et al., 2016).
1/1/2020

Decreased from 3 to 3
Description
A SNP in the XPO1 gene (rs6735330) was found to associate with autism in four cohorts, being significant in ASD-CARC cohorts (P-value following false discovery rate correction for multiple testing of 1.29E-05), the AGRE cohort [P(FDR)=0.0011] and the combined families [P(FDR)=2.34E-09] (Liu et al., 2011). XPO1 has been proposed to be a candidate gene for 2p16.1-p15 microdeletion syndrome, a neurodevelopmental disorder in which many patients present with autism or autistic features. Functional analysis of candidate genes for 2p16.1-p15 microdeletion syndrome in zebrafish found that knockdown of xpo1a, one of the two copies of XPO1 in zebrafish, resulted in significant microcephaly and abnormal body shape (Bagheri et al., 2016).
10/1/2019

Decreased from 4 to 3
New Scoring Scheme
Description
A SNP in the XPO1 gene (rs6735330) was found to associate with autism in four cohorts, being significant in ASD-CARC cohorts (P-value following false discovery rate correction for multiple testing of 1.29E-05), the AGRE cohort [P(FDR)=0.0011] and the combined families [P(FDR)=2.34E-09] (Liu et al., 2011). XPO1 has been proposed to be a candidate gene for 2p16.1-p15 microdeletion syndrome, a neurodevelopmental disorder in which many patients present with autism or autistic features. Functional analysis of candidate genes for 2p16.1-p15 microdeletion syndrome in zebrafish found that knockdown of xpo1a, one of the two copies of XPO1 in zebrafish, resulted in significant microcephaly and abnormal body shape (Bagheri et al., 2016).
7/1/2017

Decreased from 4 to 4
Description
A SNP in the XPO1 gene (rs6735330) was found to associate with autism in four cohorts, being significant in ASD-CARC cohorts (P-value following false discovery rate correction for multiple testing of 1.29E-05), the AGRE cohort [P(FDR)=0.0011] and the combined families [P(FDR)=2.34E-09] (Liu et al., 2011). XPO1 has been proposed to be a candidate gene for 2p16.1-p15 microdeletion syndrome, a neurodevelopmental disorder in which many patients present with autism or autistic features. Functional analysis of candidate genes for 2p16.1-p15 microdeletion syndrome in zebrafish found that knockdown of xpo1a, one of the two copies of XPO1 in zebrafish, resulted in significant microcephaly and abnormal body shape (Bagheri et al., 2016).
10/1/2016

Increased from to 4
Description
A SNP in the XPO1 gene (rs6735330) was found to associate with autism in four cohorts, being significant in ASD-CARC cohorts (P-value following false discovery rate correction for multiple testing of 1.29E-05), the AGRE cohort [P(FDR)=0.0011] and the combined families [P(FDR)=2.34E-09] (Liu et al., 2011). XPO1 has been proposed to be a candidate gene for 2p16.1-p15 microdeletion syndrome, a neurodevelopmental disorder in which many patients present with autism or autistic features. Functional analysis of candidate genes for 2p16.1-p15 microdeletion syndrome in zebrafish found that knockdown of xpo1a, one of the two copies of XPO1 in zebrafish, resulted in significant microcephaly and abnormal body shape (Bagheri et al., 2016).
Krishnan Probability Score
Score 0.56920789488959
Ranking 1054/25841 scored genes
[Show Scoring Methodology]
ExAC Score
Score 0.99999956749666
Ranking 256/18225 scored genes
[Show Scoring Methodology]
Sanders TADA Score
Score 0.9394771877121
Ranking 14224/18665 scored genes
[Show Scoring Methodology]
Larsen Cumulative Evidence Score
Score 3
Ranking 367/461 scored genes
[Show Scoring Methodology]
Zhang D Score
Score 0.20174229520868
Ranking 4236/20870 scored genes
[Show Scoring Methodology]